HRT Financial’s Catheter Precision VTAK Stock Holding History
Bought
Maintained
Sold
Other funds holding VTAK
VF
TRCT
AF
PUI
HI
SS
HRT Financial's VTAK Position: Q1 2026 in Review
HRT Financial opened a new position in Catheter Precision (VTAK) in Q1 2026: 11,276 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #3631 among its holdings. This is a return to the name: HRT Financial previously reported a position in VTAK as recently as Q2 2025.
HRT Financial first reported a position in VTAK in Q3 2022 and has held it in 4 quarters since. The position peaked at $42K in Q2 2025. 12 funds tracked by Wall St. Rank hold VTAK as of Q1 2026.
- HRT Financial held 11,276 shares of Catheter Precision worth $11K as of Q1 2026.
- Catheter Precision was a new HRT Financial position in Q1 2026.
- Catheter Precision made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3631 holding.
- HRT Financial first reported a position in Catheter Precision in Q3 2022 and has held it in 4 quarters since.
- HRT Financial's Catheter Precision position peaked at $42K in Q2 2025.
- 12 funds tracked by Wall St. Rank held Catheter Precision as of Q1 2026.
Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.